Related Experiment Video
Updated: Jul 12, 2026

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
Special Considerations in Atopic Dermatitis in Young Children
Mudra Bhatt1, Karan Lal2, Nanette B Silverberg3
1Government Medical College, Bhavnagar, India.
Insights
Managing atopic dermatitis (AD) in young children requires recognizing early signs across all skin types and considering triggers, comorbidities, and safe therapeutics. Age-based care is crucial for preventing long-term issues and enhancing the child-parent experience.
Area of Science:
- Pediatrics
- Dermatology
- Allergy & Immunology
Background:
- Atopic dermatitis (AD) commonly initiates in early childhood, affecting diverse skin types.
- Early recognition of AD manifestations, triggers, and associated conditions is essential for effective management.
Purpose of the Study:
- To outline key considerations for managing atopic dermatitis in young children.
- To emphasize age-based strategies for optimizing care and preventing long-term comorbidities.
Main Methods:
- Review of current pediatric dermatology literature on atopic dermatitis management.
- Synthesis of age-specific challenges and therapeutic considerations for infants and young children.
Main Results:
- Management requires attention to medication absorption risks, xerosis, and infection susceptibility.
- Care plans must be parent-acceptable, safe, and consider vaccination efficacy and systemic agent safety.
- Growth, development, sensory development, and teething eruptions are additional pediatric concerns.
Conclusions:
- Implementing age-based considerations supports high-quality care for pediatric atopic dermatitis.
- Preventing long-term comorbidities is a primary objective in early childhood AD management.
- Optimizing the patient-parent experience is integral to successful atopic dermatitis treatment in young children.
Abstract:
Atopic dermatitis (AD) begins in early childhood in the majority of children. Addressing AD in small children includes recognition of the early presentations of disease in all skin types, triggers, comorbidities, and therapeutics. These include risk of medication absorption, more xerosis, infections, and creating management plans that are acceptable to parents/caregivers, while offering safety. Vaccination efficacy, safety on systemic agents, growth and development, tactile sensory development, and teething-related facial eruptions of early childhood are additional concerns. Prevention of long-term comorbidities is the highest goal. Using age-based considerations helps support excellence in care and improved patient-parent experience.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Acne Infection
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...

